⌘+K

Pulse Explore Communities Researchers Journals

Home Communities Explore

December 18, 2025

Supplementary Figure S9 from Low OLFM1 and BMP6 Expression Predicts Recurrence in Early-Stage Nonsquamous NSCLC with Pure Solid Tumor Appearance

Kenichi Suda Yukihiro Yoshida Hidenori Sato Shuta Ohara Akira Hamada Masaya Yotsukura Kouya Shiraishi Ryuji Hamamoto Yasutaka Chiba Takashi Kohno Yasushi Yatabe Shun‐ichi Watanabe Yasuhiro Tsutani Tetsuya Mitsudomi

View at Publisher

Ask AI

Bookmark

Share

Key Points

To investigate the prognostic significance of olfm1 and bmp6 in early-stage nonsquamous NSCLC.
Analysis of olfm1 and bmp6 expression levels
Stage-specific analysis of patients with pure solid tumor appearance
Identified olfm1 and bmp6 expression levels as predictors of recurrence.
Solid tumor appearance correlated with recurrence risk in early-stage cases.

No abstract yet

We only have this paper's title and publication details.

Read it at the source→

Implication

Analysis of olfm1 and bmp6 expressions predicts recurrence in early-stage nonsquamous nsclc, suggesting their prognostic value.

Abstract

Figure S9. Prognostic implications of BMP6 and OLFM1 (stage-specific analysis).

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Suda et al. (2025) studied this question.

synapsesocial.com/papers/69449a922f0218eca950877f https://doi.org/10.1158/2767-9764.30908576

View at Publisher

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Supplementary Figure S8 from Low <i>OLFM1</i> and <i>BMP6</i> Expression Predicts Recurrence in Early-Stage Nonsquamous NSCLC with Pure Solid Tumor Appearance2025
2Supplementary Figure S11 from Low <i>OLFM1</i> and <i>BMP6</i> Expression Predicts Recurrence in Early-Stage Nonsquamous NSCLC with Pure Solid Tumor Appearance2025
3Supplementary Figure S10 from Low <i>OLFM1</i> and <i>BMP6</i> Expression Predicts Recurrence in Early-Stage Nonsquamous NSCLC with Pure Solid Tumor Appearance2025
4Supplementary Figure S6 from Low <i>OLFM1</i> and <i>BMP6</i> Expression Predicts Recurrence in Early-Stage Nonsquamous NSCLC with Pure Solid Tumor Appearance2025
5Supplementary Figure S3 from Low <i>OLFM1</i> and <i>BMP6</i> Expression Predicts Recurrence in Early-Stage Nonsquamous NSCLC with Pure Solid Tumor Appearance2025

Supplementary Figure S5 from Low <i>OLFM1</i> and <i>BMP6</i> Expression Predicts Recurrence in Early-Stage Nonsquamous NSCLC with Pure Solid Tumor Appearance2025
Supplementary Figure S1 from Low <i>OLFM1</i> and <i>BMP6</i> Expression Predicts Recurrence in Early-Stage Nonsquamous NSCLC with Pure Solid Tumor Appearance2025
Table 2 from Low <i>OLFM1</i> and <i>BMP6</i> Expression Predicts Recurrence in Early-Stage Nonsquamous NSCLC with Pure Solid Tumor Appearance2025